Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer

British Journal of Cancer

Volumn 78, Issue 6, 1998, Pages 771-773

  Lehrer, S ^a,b   Fodor, F ^a   Stock, R G ^a   Stone, N N ^a   Eng, C ^a   Song, H K ^a   McGovern, M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

BRCA1; BRCA2; Jewish mutations; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DELETION MUTANT; DOT HYBRIDIZATION; ETHNIC GROUP; FAMILIAL CANCER; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; HUMAN CELL; JEW; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE;

EID: 0031711516     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.576     Document Type: Article

References (22)

1. Boring CC, Squires TS, Tong T and Montgomery S (1994) Cancer statistics 1994 Ca 44: 7-26 Eastman P (1996) Search for prostate cancer gene sites may succeed in 1996. J Natl Cancer Inst 88: 952-953
2. Fitzgerald MG, MacDonald DJ, Kranier M, Hoover I, O'Neil E, Unsal H, Silva Arrieto S, Finkelstein DM, Beer Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber, JE, Duda, RB, Mayzel, KA, Isselbacher KJ, Friend, SH and Haber DA, (1996) Germ-line BRCA1 mutation in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334: 143-149
3. Ford D, Easton DF, Bishop DT, Narod SA and Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343: 692-695
4. Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, Lee MK, Goode EL, Rowell SE and King MC (1995) Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 57: 1284-1297
5. Gao X, Zacharek A, Grignon DJ, Sakr W, Powell IJ, Porter AT and Honn KV (1995a) Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer. Oncogene 11: 1241-1247
6. Gao X, Zacharek A, Salkowski A, Grignon DJ, Sakr W, Porter AT and Honn KV (1995b). Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 55: 1002-1005
7. Giovannucci E, Tosteson TD, Speizer FE, Ascherio A, Vessey MP and Coldiz GA (1993) A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA 269: 878-882
8. Isaacs SD, Kiemeney LA, Baffoe Bonnie A, Beaty TH and Walsh PC (1995) Risk of cancer in relatives or prostate cancer probands. J Natl Cancer Inst 87: 991-996
9. Langston AA, Stanford JL, Wicklund KG, Thompson, JD, Blazej RG and Ostrander EA (1996a) Germ-line BRCA1 mutations in selected men with prostate cancer. Am J Hum Genet 58: 881-885
10. Langston AA, Malone KE, Thompson JD, Daling JR and Ostrander EA (1996b) BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 334: (3): 137-142
11. Miki Y, Swensen J, Shattuck Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayanath P, Ward J, Tonin P, Narod S, Bristow PK, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71
12. Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H and Offit K (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature Genet 14: 188-190
13. Pienta KJ and Esper PS (1993) Risk factors for prostate cancer. Ann Int Med 118: 793-803
14. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY
15. Sellers TA, Potter JD, Rich SS, Drinkard CR, Bostick RM, Kushi LH, Zheng W and Folsom AR (1994) Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst 86: 1860-1865
16. Smith JR, Freije D, Carpten JD, Grönberg H, Xu J, Isaacs SD, Broenstein MD, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber J, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM and Isaacs WB (1997). Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274: 1371-1374
17. Stephenson J (1996) Prostate cancer gene hunters track their quarry. JAMA 276: 861-863
18. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS and Brody LC (1995) The carrier frequence of the BRCA 1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 11: 198-200
19. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC and Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408
20. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Hoew GR, West DW, Teh CZ and Stamey T (1995) Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 141: 732-740
21. Williams BJ, Jones E, Zhu XL, Steele MR, Stephenson RA, Rohr LR and Brothman AR (1996) Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer. J Urol 155: 720-725
22. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldsar DE and Stratton MR (1994) Idealization of a breast eaneer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088-2040